Navigation Links
Latest drug shows promise in multiple myeloma

According to researchers, many trials show that a new type of drug can assist patients with multiple myeloma who have failed to respond to other treatments.// Multiple myeloma is an incurable cancer of the bone marrow. Researchers at Dana-Farber Cancer Institute have been assessing a new drug, called bortezomib, in a group of 180 patients who had not been helped by other forms of treatment. In the first sub-group, consisting of 65 patients, 30 per cent showed at least a partial response, with some showing a complete response, in which no sign of active disease could be detected.

In all, 78 per cent either had their condition either stabilize or improve from the start of the therapy, and some were still showing a positive response up to a year later. Bortezomib is a new kind of drug called a proteasome inhibitor. It acts on tiny structures called proteasomes within cells and so stops myeloma cells from multiplying.


'"/>




Page: 1

Related medicine news :

1. Latest device for identifying Melanomas
2. Latest discovery on Autism
3. Latest device for cardiac revival under test
4. Latest technique for asthma treatment
5. Latest Findings On The Deadly Disease - SARS
6. Latest Tumor Classification More Informative
7. The Latest Preventative Treatment Option for Prostate Cancer
8. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
9. A Latest Study Links Fish To Stroke
10. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
11. Lovers Latest Hang Outs – Railway Platform

Post Your Comments:
(Date:11/24/2009)...,, ChangesMustBeMadetoUSPSTFRepresentationan...Newswire-USNewswire/-- SeveralsectionsofSenateheal...thatinsuranceentitiessuchasprivateinsurers,Medicar...ivingaspecificgradefromtheU.S.PreventativeServices...vicesforwomen40-49,wouldonlyrequirecoverageofbienn...
(Date:11/24/2009)... This release is available in French and Span...anada have found a suicide gene, called ,gene E,...from breast, lung and colon cancer, and prevents t...at its use to fight cancer can reduce the potent d...ore effective treatment for cancer. , This resea...
(Date:11/24/2009)... Reston, Va.SNM will hold its Conjoint Mid-Winter...Convention Center in Albuquerque, N.M. This year, ...ium with the 2010 Annual Meeting and Educational S...ne (ACNM), the Nanomedicine and Molecular Imaging ...orkshop. The seven-day event offers participants a...
(Date:11/24/2009)...Pumping ability reduced in those with undesirable ..., Nov. 24 (HealthDay News) -- Abnormal cholesterol...rt failure, a new study has found. , U.S. resea...National Heart, Lung, and Blood Institute,s Framin...e age 44, had coronary heart disease at the start ...
(Date:11/24/2009)... zioTerm Software will be...mmunities , (PRWEB) -- Zi...n and analysis software for medical imaging, is of... free to the academic and research communities. T...iewing DICOM 3.0-compatible imaging data from CT, ...
Breaking Medicine News(10 mins):Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 3Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:SNM's Conjoint Mid-Winter Meetings offer 4 scientific meetings in 1 location 2Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:Ziosoft Releases Free zioTerm Basic 2D/3D Software Application 2
...ssee and Horizon Blue Cross Blue Shield of New...ology , , CHATTANOOGA, Tenn., NEWARK, N.J. and W...n for prescription medication requires phones call...erate this process. , , (Logo: http://www.new...
...amily of Iraq and Afghanistan Veterans...tion and readjustment challenges facing Iraq and A...Afghanistan Veterans of America (IAVA) joined the ...2008, the first series of ads reaches out to veter...
...0, 2009) Van Andel Research Institute (VARI) Re... awarded the AACR-Sanofi-Aventis Scholar-in-Traini...t the American Association for Cancer Research (AA...in Denver from April 18-22, where nearly 17,000 sc...
...stinguished professor at Kansas State University,s...nt renewal of $1.48 million from The National Eye ...study the cornea. , "The NIH renewal will make Co...earch. , From the beginning, Conrad has been fasc...
...istory data supports heredity,s role in shoulder t...h relatives who have experienced rotator cuff te...s themselves, according to a study published in th... cuff disease," said Robert Z. Tashjian, MD, assoc...
...risis improved long-term outcomes, study found , ...patients a cholesterol-busting statin drug during ... incidence of longer-term problems, Czech research...ndrome who received the drugs, compared to those w...
Other Medicine News:Health News:Electronic Prior Authorization Program to Help Patients Get Faster Access to Prescription Medication 2Health News:Electronic Prior Authorization Program to Help Patients Get Faster Access to Prescription Medication 3Health News:Electronic Prior Authorization Program to Help Patients Get Faster Access to Prescription Medication 4Health News:Electronic Prior Authorization Program to Help Patients Get Faster Access to Prescription Medication 5Health News:Video: IAVA and Ad Council Build on Success of Groundbreaking Veterans Campaign with New Friends and Family Element 2Health News:Video: IAVA and Ad Council Build on Success of Groundbreaking Veterans Campaign with New Friends and Family Element 3Health News:Video: IAVA and Ad Council Build on Success of Groundbreaking Veterans Campaign with New Friends and Family Element 4Health News:VARI researcher chosen for highly competitive Scholar-in-Training Award 2Health News:K-State professor awarded $1.48 million to study LASIK complictions 2Health News:K-State professor awarded $1.48 million to study LASIK complictions 3Health News:Rotator Cuff Tears: Are They All in the Family? 2Health News:Rotator Cuff Tears: Are They All in the Family? 3Health News:Cholesterol Drugs May Help in Cardiac Emergency 2
(Date:11/24/2009)...FirstCall/--EchoTherapeutics,Inc.(OTCBulletinBoard...)tCGMSystemasanon-invasive,wireless,transdermalcon...TM)SkinPrepSystemfortransdermaldrugdelivery,announ...xecutiveOfficer,willpresentatthe13thAnnualBiotecha...eNewYorkSocietyofSecuritiesAnalysts,at2:05onDecemb...
(Date:11/24/2009)...stCall/--ZimmerHoldings,Inc.(NYSE: ZMH ;SIX:ZMH)an...perJaffrayHealthCareConferenceinNewYork,NewYork,on...ebcastofthepresentationcanbeaccessedviaZimmer,sInv... .Thewebcastwillbearchivedforreplayfollowingthecon...27andheadquarteredinWarsaw,Indiana,Zimmerdesigns,d...
(Date:11/24/2009)...all/--OptimerPharmaceuticals,Inc.(Nasdaq: OPTR )is...hCareConferenceatTheNewYorkPalaceinNewYorkCityonDe...tp://www.newscom.com/cgi-bin/prnh/20090413/LA97352...llbeaccessibleontheInvestorspageoftheCompany,swebs...tationwillbeavailableatthesamelocationfor30daysfol...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 1PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 2PLC Systems Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6134 3Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 1Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 2Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 3Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 4Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 5Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 6Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 7Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 8Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 9Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 10Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 1Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 2Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 3
...--Jul 6, 2007 - Neurologix, Inc.,(OTCBB:NRGX), a b...,innovative gene therapies for the brain and centr...y will present at the Third Annual,C.E. Unterberg ...10, 2007 at 4:30 pm ET at The Mandarin Oriental Ho...ficer John Mordock will discuss,Neurologix,s busin...
...--Jul 5, 2007 - Array BioPharma Inc.,(Nasdaq: ARRY...,Robert E. Conway, will speak at the C.E Unterbeg...New York City. The public is,welcome to participat... BioPharma website. -0-, ,Event: C.E Unte...: Robert E. Conway, Chief Executive Officer, ...
Other Medicine Technology:
z-box™
NOW Legionella
ThyroTest® TSH
BinaxNOW Influenza A & B Test
Medicine Products: